PILONIDAL SINUS: CONVENTIONAL CARE VERSUS NEGATIVE PRESSURE THERAPY. (SINUS-TPN)
Primary Purpose
Pilonidal Sinus, Wound Heal
Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Negative pressure therapy
Conventional wound care
Sponsored by
About this trial
This is an interventional treatment trial for Pilonidal Sinus focused on measuring Negative presure therapy
Eligibility Criteria
Inclusion Criteria:
- All patients diagnosed with SP (recurrence or not), who have undergone surgery.
- Minimum depth of the wound 1.5 cm.
Exclusion Criteria:
- Inferior margin of the surgical wound is located less than 3 cm from the anus
- Patients under 16 years of age
- Unable to track
- Diagnosed psychiatric illness
- Patients diagnosed with hidradenitis
- Uncontrolled diabetics
- Immunocompromised (kidney or liver transplant, chronic treatment with corticosteroids, haematological disease, neoplastic disease undergoing chemotherapy)
Sites / Locations
- Bellvitge University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Conventional care
Negative pressure therapy
Arm Description
Outcomes
Primary Outcome Measures
Cicatrization
Time in days from surgery to complete epithelialization of the wound, assessed by the dressing nurse and surgeon.
Secondary Outcome Measures
Wound size
Defined as wound volume measured in milliliters. In addition, the measurements of width, length and depth in cm will be collected.
Postoperative pain
Evaluated with the visual analog pain scale ranging from 0 to 10, where 0 represents no pain and 10 represents intolerable pain. It will be assessed weekly
Time of incorporation into daily activities
Time in days from surgery to incorporation into daily activities as reported by the patients in the weekly evaluation
Patient quality of life
Evaluated by applying the SF-36 questionnaire in both groups at 15 days, 30 days, and monthly until healing. A total score will be calculated in each of the 8 sections and converted to a scale from 0 to 100, with a score of 0 equivalent to maximum disability and a score of 100 equivalent to no disability.
Patient satisfaction
Reported by the patient on a scale of 0 to 10, where 0 corresponds to "totally unsatisfactory" and 10 corresponds to "totally satisfactory". The score obtained at the end of healing will be recorded. It will be done when healing is complete.
Adverse effects related to the treatments
Reported adverse effects
Cost effectiveness
Cost effectiveness of NPT
Disease recurrence at follow-up
Disease recurrence will be assessed 1 year after surgery.
Full Information
NCT ID
NCT05474911
First Posted
July 23, 2022
Last Updated
July 23, 2022
Sponsor
Sebastiano Biondo
Collaborators
Hospital Universitari de Bellvitge
1. Study Identification
Unique Protocol Identification Number
NCT05474911
Brief Title
PILONIDAL SINUS: CONVENTIONAL CARE VERSUS NEGATIVE PRESSURE THERAPY.
Acronym
SINUS-TPN
Official Title
RANDOMIZED COMPARATIVE CLINICAL STUDY BETWEEN TWO TREATMENT STRATEGIES IN PATIENTS WITH PILONIDAL SINUS: CONVENTIONAL CARE VERSUS NEGATIVE PRESSURE THERAPY.
Study Type
Interventional
2. Study Status
Record Verification Date
July 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 1, 2022 (Anticipated)
Primary Completion Date
September 1, 2023 (Anticipated)
Study Completion Date
December 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Sebastiano Biondo
Collaborators
Hospital Universitari de Bellvitge
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Pilonidal Sinus PS is a prevalent disease in young patients. There is currently no consensus on the surgical treatment of choice. Each method is associated with different advantages and disadvantages, as well as different recurrence rates. The ideal treatment should reduce morbidity, be associated with a short hospital stay (outpatient surgery), promote rapid healing, early return to work, and have a low recurrence rate. To date, no technique meets all these criteria. However, the NPT could meet them. The use of NPT in PS could decrease healing time, achieving an early return to work. In addition, it would avoid the need for daily dressings, which would mean lower hospital costs. However, the location of the wound (sacrum) and its proximity to the anal margin mean that its use cannot be generalized.
Although two retrospective series have recently reported good results with the use of NPT in PS, a prospective, randomized study is needed to compare healing time, recurrence rates, hospital costs, and assess quality of life for determine if this could be the treatment of choice.
Although NPT is commonly used in clinical practice (being useful in closing complex wounds, with devitalized tissues, burns and wounds with exposed tendons), to date there is not enough evidence to support its use after flattening the PS and it is for this reason that we conducted this study.
In this project there is a total absence of commercial interest in the proposal. No project related to the proposed one is currently being carried out.
Detailed Description
The study population will be made up of all patients with PS admitted to the General and Digestive Surgery service of the Hospital Universitari de Bellvitge from the start of the trial until the end of recruitment, and who meet the inclusion criteria.
Once the patients belonging to the population of interest have been identified, they will propose to participate in the clinical trial, providing complete information, as well as an information sheet with the details of the study. If you agree, the informed consent document will be provided for your signature and randomization will proceed.
Bitter et al. observed in a prospective study that the use of NTP did not reduce healing time compared to conventional closure 84 days (34-349) vs 93 days (43-264); p=0.44. However, the duration of NPT application of only 2 weeks might have been too short to see an adequate effect. Also, the small sample size could have influenced the results. On the other hand, recent publications on the use of TPN in the treatment of pilonidal sinus have shown a significant reduction in healing time (28 days) with minimal complications and adequate patient satisfaction. Taking into account the scarce evidence of the studies cited, we have decided to adopt a conservative criterion, assuming a smaller difference in time to healing between the two treatments (35 days).
To calculate the sample size, the time variable has been transformed into a logarithm. Accepting an alpha risk of 0.05 and a beta risk of 0.20 in a bilateral contrast, 94 patients, 47 subjects in the control group and 47 in the experimental group, are needed to detect a difference of 0.77. A common standard deviation of 1.26 is assumed. A rate of loss to follow-up of 10% has been estimated.
Randomization 1:1 will be performed using a statistical program at the baseline visit in outpatient clinics 48 hours after surgery, after assessing the dimensions of the wound, checking whether the participant meets the inclusion/exclusion criteria and has signed the informed consent.
For the purposes of the study and in order not to influence the type of surgery performed on patients with PS, only those patients who have undergone a flattening will be included. The 1st cure will be performed 24 hours later in the area outpatient clinic and will consist of removing the dressing, washing with physiological serum and placing a dry dressing.
48 hours after surgery, patients will be evaluated in outpatient clinics at our hospital. The dressing will be removed from the wound and after washing with serum, it will be checked if the patient meets the inclusion criteria. If you meet them, you will be offered to participate in the study and once you have signed the informed consent, randomization will proceed.
The patients will be monitored in person in outpatient clinics (CEX) by two members of the research team, made up of a nurse specialized in cures and a doctor specialized in surgery.
During the follow-up visits, a conventional dressing will be performed or the negative pressure system will be changed. Symptomatology and quality of life data will be collected through validated surveys.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pilonidal Sinus, Wound Heal
Keywords
Negative presure therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
94 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Conventional care
Arm Type
Active Comparator
Arm Title
Negative pressure therapy
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Negative pressure therapy
Intervention Description
The wound will be cleaned (irrigation with Physiological Serum), the cavity and the perilesional area will be dried with gauze. A skin protection spray will be applied to avoid irritation of the skin around the wound due to the adhesive of the dressing. The cavity will be filled with a sponge. When the depth of the wound is less than 1.5 cm, it will not be necessary to fill the defect. The appropriate dressing will be applied to the size of the incision, reinforcing the edges, and it will be connected to the TPN device, ensuring correct functionality.
Intervention Type
Other
Intervention Name(s)
Conventional wound care
Intervention Description
The wound will be cleaned with physiological serum irrigation, the cavity will be dried with gauzes and filled with a dressing made of cellulose and silver. A skin protection spray will be applied to avoid irritation of the skin around the wound due to the adhesive of the dressing.
Primary Outcome Measure Information:
Title
Cicatrization
Description
Time in days from surgery to complete epithelialization of the wound, assessed by the dressing nurse and surgeon.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Wound size
Description
Defined as wound volume measured in milliliters. In addition, the measurements of width, length and depth in cm will be collected.
Time Frame
1 year
Title
Postoperative pain
Description
Evaluated with the visual analog pain scale ranging from 0 to 10, where 0 represents no pain and 10 represents intolerable pain. It will be assessed weekly
Time Frame
1 year
Title
Time of incorporation into daily activities
Description
Time in days from surgery to incorporation into daily activities as reported by the patients in the weekly evaluation
Time Frame
1 year
Title
Patient quality of life
Description
Evaluated by applying the SF-36 questionnaire in both groups at 15 days, 30 days, and monthly until healing. A total score will be calculated in each of the 8 sections and converted to a scale from 0 to 100, with a score of 0 equivalent to maximum disability and a score of 100 equivalent to no disability.
Time Frame
1 year
Title
Patient satisfaction
Description
Reported by the patient on a scale of 0 to 10, where 0 corresponds to "totally unsatisfactory" and 10 corresponds to "totally satisfactory". The score obtained at the end of healing will be recorded. It will be done when healing is complete.
Time Frame
1 year
Title
Adverse effects related to the treatments
Description
Reported adverse effects
Time Frame
1 year
Title
Cost effectiveness
Description
Cost effectiveness of NPT
Time Frame
1 year
Title
Disease recurrence at follow-up
Description
Disease recurrence will be assessed 1 year after surgery.
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
All patients diagnosed with SP (recurrence or not), who have undergone surgery.
Minimum depth of the wound 1.5 cm.
Exclusion Criteria:
Inferior margin of the surgical wound is located less than 3 cm from the anus
Patients under 16 years of age
Unable to track
Diagnosed psychiatric illness
Patients diagnosed with hidradenitis
Uncontrolled diabetics
Immunocompromised (kidney or liver transplant, chronic treatment with corticosteroids, haematological disease, neoplastic disease undergoing chemotherapy)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ana Gálvez Saldaña
Phone
+34 932607500
Email
ana.galvez@bellvitgehospital.cat
First Name & Middle Initial & Last Name or Official Title & Degree
Domenico Fraccalvieri
Phone
+34 932607500
Email
domenico@bellvitgehospital.cat
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sebastiano Biondo, MD
Organizational Affiliation
Hospital Universitari de Bellvitge
Official's Role
Study Chair
Facility Information:
Facility Name
Bellvitge University Hospital
City
L'Hospitalet de Llobregat
State/Province
Barcelona
ZIP/Postal Code
08907
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sebastiano Biondo, MD, PhD
Phone
+34 932607485
Email
sbn.biondo@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
34254748
Citation
Roldon Golet M, Siles Hinojosa A, Gonzalez Ruiz Y, Escartin Villacampa R, Goded Broto I, Bragagnini Rodriguez P. Pilonidal sinus in adolescence: is there an ideal surgical approach? Cir Pediatr. 2021 Jul 1;34(3):119-124. English, Spanish.
Results Reference
background
PubMed Identifier
33728570
Citation
Kumar M, Clay WH, Lee MJ, Brown SR, Hind D. A mapping review of sacrococcygeal pilonidal sinus disease. Tech Coloproctol. 2021 Jun;25(6):675-682. doi: 10.1007/s10151-021-02432-9. Epub 2021 Mar 16.
Results Reference
background
PubMed Identifier
31848678
Citation
Caliskan M, Kosmaz K, Subasi IE, Acar A, Evren I, Bas G, Atayoglu AT. Comparison of Common Surgical Procedures in Non-complicated Pilonidal Sinus Disease, a 7-Year Follow-Up Trial. World J Surg. 2020 Apr;44(4):1091-1098. doi: 10.1007/s00268-019-05331-1.
Results Reference
background
PubMed Identifier
34101331
Citation
Luedi MM, Schober P, Stauffer VK, Diekmann M, Andereggen L, Doll D. Gender-specific prevalence of pilonidal sinus disease over time: A systematic review and meta-analysis. ANZ J Surg. 2021 Jul;91(7-8):1582-1587. doi: 10.1111/ans.16990. Epub 2021 Jun 7.
Results Reference
background
PubMed Identifier
32792519
Citation
Bi S, Sun K, Chen S, Gu J. Surgical procedures in the pilonidal sinus disease: a systematic review and network meta-analysis. Sci Rep. 2020 Aug 13;10(1):13720. doi: 10.1038/s41598-020-70641-7.
Results Reference
background
PubMed Identifier
20091589
Citation
Al-Khamis A, McCallum I, King PM, Bruce J. Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD006213. doi: 10.1002/14651858.CD006213.pub3.
Results Reference
background
PubMed Identifier
30948198
Citation
Grabowski J, Oyetunji TA, Goldin AB, Baird R, Gosain A, Lal DR, Kawaguchi A, Downard C, Sola JE, Arthur LG, Shelton J, Diefenbach KA, Kelley-Quon LI, Williams RF, Ricca RL, Dasgupta R, St Peter SD, Somme S, Guner YS, Jancelewicz T. The management of pilonidal disease: A systematic review. J Pediatr Surg. 2019 Nov;54(11):2210-2221. doi: 10.1016/j.jpedsurg.2019.02.055. Epub 2019 Mar 19.
Results Reference
background
PubMed Identifier
27311698
Citation
Iesalnieks I, Ommer A, Petersen S, Doll D, Herold A. German national guideline on the management of pilonidal disease. Langenbecks Arch Surg. 2016 Aug;401(5):599-609. doi: 10.1007/s00423-016-1463-7. Epub 2016 Jun 16.
Results Reference
background
PubMed Identifier
29449548
Citation
Stauffer VK, Luedi MM, Kauf P, Schmid M, Diekmann M, Wieferich K, Schnuriger B, Doll D. Common surgical procedures in pilonidal sinus disease: A meta-analysis, merged data analysis, and comprehensive study on recurrence. Sci Rep. 2018 Feb 15;8(1):3058. doi: 10.1038/s41598-018-20143-4.
Results Reference
background
PubMed Identifier
18390914
Citation
McCallum IJ, King PM, Bruce J. Healing by primary closure versus open healing after surgery for pilonidal sinus: systematic review and meta-analysis. BMJ. 2008 Apr 19;336(7649):868-71. doi: 10.1136/bmj.39517.808160.BE. Epub 2008 Apr 7.
Results Reference
background
PubMed Identifier
30640830
Citation
Johnson EK, Vogel JD, Cowan ML, Feingold DL, Steele SR; Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons' Clinical Practice Guidelines for the Management of Pilonidal Disease. Dis Colon Rectum. 2019 Feb;62(2):146-157. doi: 10.1097/DCR.0000000000001237. No abstract available.
Results Reference
background
PubMed Identifier
34417712
Citation
Calisir A, Ece I. Comparison of the Keystone flap and the Limberg flap technique in the surgical treatment of pilonidal sinus disease. Updates Surg. 2021 Dec;73(6):2341-2346. doi: 10.1007/s13304-021-01153-w. Epub 2021 Aug 20.
Results Reference
background
PubMed Identifier
30066108
Citation
Prassas D, Rolfs TM, Schumacher FJ, Krieg A. Karydakis flap reconstruction versus Limberg flap transposition for pilonidal sinus disease: a meta-analysis of randomized controlled trials. Langenbecks Arch Surg. 2018 Aug;403(5):547-554. doi: 10.1007/s00423-018-1697-7. Epub 2018 Jul 31.
Results Reference
background
PubMed Identifier
33524646
Citation
Maranna H, Lal P, Mishra A, Bains L, Sawant G, Bhatia R, Kumar P, Beg MY. Negative pressure wound therapy in grade 1 and 2 diabetic foot ulcers: A randomized controlled study. Diabetes Metab Syndr. 2021 Jan-Feb;15(1):365-371. doi: 10.1016/j.dsx.2021.01.014. Epub 2021 Jan 23.
Results Reference
background
PubMed Identifier
30328611
Citation
Liu Z, Dumville JC, Hinchliffe RJ, Cullum N, Game F, Stubbs N, Sweeting M, Peinemann F. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database Syst Rev. 2018 Oct 17;10(10):CD010318. doi: 10.1002/14651858.CD010318.pub3.
Results Reference
background
PubMed Identifier
34963451
Citation
Kojima K, Goto M, Nagashima Y, Saito Y, Kawai M, Takebe S, Egawa A, Tanba M, Ishikawa K, Matsuoka H, Masaki T, Sunami E, Ohura N, Teruya K, Eto K, Nozawa K, Sakamoto K, Funahashi K. Effectiveness of negative pressure wound therapy for the wound of ileostomy closure: a multicenter, phase II randomized controlled trial. BMC Surg. 2021 Dec 28;21(1):442. doi: 10.1186/s12893-021-01446-2.
Results Reference
background
PubMed Identifier
34763444
Citation
Chen L, Zhang S, Da J, Wu W, Ma F, Tang C, Li G, Zhong D, Liao B. A systematic review and meta-analysis of efficacy and safety of negative pressure wound therapy in the treatment of diabetic foot ulcer. Ann Palliat Med. 2021 Oct;10(10):10830-10839. doi: 10.21037/apm-21-2476.
Results Reference
background
PubMed Identifier
26994715
Citation
Hyldig N, Birke-Sorensen H, Kruse M, Vinter C, Joergensen JS, Sorensen JA, Mogensen O, Lamont RF, Bille C. Meta-analysis of negative-pressure wound therapy for closed surgical incisions. Br J Surg. 2016 Apr;103(5):477-86. doi: 10.1002/bjs.10084.
Results Reference
background
PubMed Identifier
28807639
Citation
Searle RJ, Myers D. A survey of caesarean section surgical site infections with PICO Single Use Negative Pressure Wound Therapy System in high-risk patients in England and Ireland. J Hosp Infect. 2017 Oct;97(2):122-124. doi: 10.1016/j.jhin.2017.02.023. Epub 2017 Aug 12.
Results Reference
background
PubMed Identifier
32818259
Citation
Meyer J, Roos E, Abbassi Z, Buchs NC, Ris F, Toso C. Prophylactic Negative-pressure Wound Therapy Prevents Surgical Site Infection in Abdominal Surgery: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies. Clin Infect Dis. 2021 Dec 6;73(11):e3804-e3813. doi: 10.1093/cid/ciaa1203.
Results Reference
background
PubMed Identifier
34404842
Citation
Frear CC, Griffin BR, Cuttle L, Kimble RM, McPhail SM. Cost-effectiveness of adjunctive negative pressure wound therapy in paediatric burn care: evidence from the SONATA in C randomised controlled trial. Sci Rep. 2021 Aug 17;11(1):16650. doi: 10.1038/s41598-021-95893-9.
Results Reference
background
PubMed Identifier
33609382
Citation
Saunders C, Nherera LM, Horner A, Trueman P. Single-use negative-pressure wound therapy versus conventional dressings for closed surgical incisions: systematic literature review and meta-analysis. BJS Open. 2021 Jan 8;5(1):zraa003. doi: 10.1093/bjsopen/zraa003.
Results Reference
background
PubMed Identifier
34840300
Citation
Cheung DC, Muaddi H, de Almeida JR, Finelli A, Karanicolas P. Cost-Effectiveness Analysis of Negative Pressure Wound Therapy to Prevent Surgical Site Infection After Elective Colorectal Surgery. Dis Colon Rectum. 2022 May 1;65(5):767-776. doi: 10.1097/DCR.0000000000002154.
Results Reference
background
PubMed Identifier
34392436
Citation
Berner-Hansen V, Oma E, Willaume M, Jensen KK. Prophylactic negative pressure wound therapy after open ventral hernia repair: a systematic review and meta-analysis. Hernia. 2021 Dec;25(6):1481-1490. doi: 10.1007/s10029-021-02485-7. Epub 2021 Aug 14.
Results Reference
background
PubMed Identifier
33905552
Citation
Gao J, Wang Y, Song J, Li Z, Ren J, Wang P. Negative pressure wound therapy for surgical site infections: A systematic review and meta-analysis. J Adv Nurs. 2021 Oct;77(10):3980-3990. doi: 10.1111/jan.14876. Epub 2021 Apr 27. Erratum In: J Adv Nurs. 2022 Jun;78(6):1848.
Results Reference
background
PubMed Identifier
24917894
Citation
Payne C, Edwards D. Application of the Single Use Negative Pressure Wound Therapy Device (PICO) on a Heterogeneous Group of Surgical and Traumatic Wounds. Eplasty. 2014 Apr 28;14:e20. eCollection 2014.
Results Reference
background
PubMed Identifier
31907033
Citation
Kim S, Kang SI. The effectiveness of negative-pressure wound therapy for wound healing after stoma reversal: a randomised control study (SR-PICO study). Trials. 2020 Jan 6;21(1):24. doi: 10.1186/s13063-019-3925-z.
Results Reference
background
PubMed Identifier
34176001
Citation
Milone M, Basso L, Manigrasso M, Pietroletti R, Bondurri A, La Torre M, Milito G, Pozzo M, Segre D, Perinotti R, Gallo G. Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of pilonidal disease. Tech Coloproctol. 2021 Dec;25(12):1269-1280. doi: 10.1007/s10151-021-02487-8. Epub 2021 Jun 27.
Results Reference
background
PubMed Identifier
34455675
Citation
Hannan E, Harding T, Feizal H, Martin S. Negative pressure wound therapy following excision of pilonidal sinus disease: A retrospective review. Colorectal Dis. 2021 Nov;23(11):2961-2966. doi: 10.1111/codi.15890. Epub 2021 Sep 12.
Results Reference
background
PubMed Identifier
33755853
Citation
Giordano P, Schembari E, Keshishian K, Leo CA. Negative pressure-assisted endoscopic pilonidal sinus treatment. Tech Coloproctol. 2021 Jun;25(6):739-743. doi: 10.1007/s10151-021-02431-w. Epub 2021 Mar 23.
Results Reference
background
Learn more about this trial
PILONIDAL SINUS: CONVENTIONAL CARE VERSUS NEGATIVE PRESSURE THERAPY.
We'll reach out to this number within 24 hrs